Emerging Insights on Adverse Events During ART and Implications for Treatment

In this live, 45-minute Webinar, pose questions and gain insights on emerging ART safety and tolerability data. Through a distinct Question and Answer format, expert faculty will practically apply these principles to address challenges you often face when initiating or modifying ART for individual patients.

Following registration, submit your questions in advance!


Key Data and Guidance on ART Safety and Tolerability (15 minutes)

Attendee Questions Answered by the Experts (30 minutes)


Date / Time
Event Details


Fidelia Bernice, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland

Aadia I. Rana, MD

Associate Professor of Medicine
Division of Infectious Diseases
The University of Alabama at Birmingham
1917 Clinic
Birmingham, Alabama

Goal Statement
The goal of this activity is to improve learners’ competence in applying the latest data on ART safety and tolerability when selecting or modifying individualized ART regimens for patients with HIV infection.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare providers who care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Individualize ART management strategies for people living with HIV integrating safety and tolerability considerations


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-195-L02-P

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.